Comparison of treatment effect sizes from pivotal and postapproval trials of novel therapeutics approved by the FDA based on surrogate markers of disease: a meta-epidemiological study. uri icon

authors

  • Wallach, Joshua D
  • Ciani, Oriana
  • Pease, Alison M
  • Gonsalves, Gregg S
  • Krumholz, Harlan M
  • Taylor, Rod S
  • Joseph S. Ross, MD, MHS

publication date

  • January 1, 2018